One of the ways that the Eisenhower Lucy Curci Cancer Center is delivering on its promise to set the standard for excellence in cancer care is by ensuring community access to a robust research program, including opportunities to participate in nearly 100 clinical trials.
Clinical trials provide a way to evaluate the safety and effectiveness of potential new treatments.They are perhaps the only way a patient can receive a new research treatment before it becomes widely available. Each study is designed to answer scientific questions and to find new and better ways to help patients by evaluating new cancer therapies, diagnostics and preventative measures.
“Clinical trials are crucial to progress in cancer care, and it is our mission at the Eisenhower Lucy Curci Cancer Center to offer the patients the very best options when it comes to treating cancer,” says Stephanie Farrell, Clinical Research Coordinator.
Doctors affiliated with the Eisenhower Lucy Curci Cancer Center are actively involved in clinical trials in an effort to determine the most effective ways to treat all types of cancer.The Center has partnered with Stanford University Medical Center enabling them to offer wider access to national trials that cover a wide range of modalities including surgery, radiation, chemotherapy, immunotherapy, gene mapping and prevention.
The Center’s research work group considers new trials on a monthly basis. Currently the Center has newly opened trials for breast cancer, lung cancer and prostate cancer. For more information on available clinical trials, contact Stephanie Farrell, Clinical Research Coordinator at 760-674-3644, or via E-mail: email@example.com.